Latest News

On November 7, 2018, FDA’s CDER approved a new version of Primatene Mist as the only OTC metered-dose inhaler. Primatene is for the temporary relief…

Key staff from PEGUS (Dr. Russ Bradford, Sarah Farnsworth, Kimberly Anderson and Clark Richardson) participated in an innovative session at the 2018 Regulatory, Scientific and…

On April 17, members of the PEGUS scientific consulting team participated in the CHPA Consumer Behavior Roundtable in Silver Spring, Maryland. The roundtable was attended…

A Self-Selection and Actual Use Trial conducted by PEGUS Research that investigated whether consumers can correctly select and use a long-acting immediate-release and extended-release 600…

Results from a US actual use trial conducted by PEGUS to evaluate consumer adherence to dosing directions for a 400 mg OTC pain reliever were…